News and price dashboard

Veea leads the board on an 8-K

The largest move in the list is Veea, up 47.3%, and the only item behind it is a headline-only SEC filing: an 8-K covering Item 5.02 (departure or election of directors and officers, and compensatory arrangements) plus an Item 8.01 "other events" disclosure. Nothing in the material explains the size of the move, so if this one matters to you, the filing itself is the place to go.

OPNW down on a Form 4

OPNW is off 17.0%. The only item attached is a VerifyMe Form 4 notice dated 9 October, and the article carries no detail beyond the filing's existence. No stated reason for the drop.

AST SpaceMobile breaks to a 52-week low

ASTS fell 10.5% and this is the most heavily covered name in the section, with seven items read in full. The driver is competitive and regulatory: the FCC authorised SpaceX to build a 15,000-satellite direct-to-cell network using its own spectrum, which cuts at AST's model of selling through wireless carriers. On top of that, investors got an early look at the FCC's 29 October agenda, which includes a proposal to open more airwaves to leasing under Supplemental Coverage from Space rules and a second proposal to auction 25 MHz in bands usable for direct-to-device. Clear Street called it a mixed signal and kept its Buy. The stock had already been weak going in: a B. Riley downgrade to Neutral on 2 October with the target cut from $85 to $65, a William Blair cut to its 2027 revenue estimate from $752m to $459m on launch delays, six consecutive earnings misses, a $125.9m write-off on the BlueBird 7 satellite failure, and a $1bn convertible offering that pushed the 45-satellite constellation target into early 2027. Shares touched $49.25 against a prior 52-week low of $49.31 and sit roughly 61% below the $133.86 high. Roth MKM kept Buy at $108 and Berenberg's Michael Filatov reaffirmed Buy, arguing the Grain Management spectrum sale to SpaceX actually raises AST's value as a carrier-aligned partner. AST's own pitch, per its CEO, is that domestic carrier partners hold about 1,000 MHz of low and mid-band spectrum its constellation can use, plus its own 45 MHz L-band allocation, targeting peak speeds near 200 Mbps. AT&T and Verizon arrangements are described as intact. Options were busy: 253,920 contracts with calls at 158,506 versus 95,414 puts, though the single biggest line was the Jan 2027 $50 put at 10,372 contracts, and three-month volatility rose 4.55 points to 81.31%. On fundamentals, GuruFocus flags a GF Score of 44/100, P/S of about 120 against a historical median near 62, and insider selling of $451.6m against $0.8m of buying over twelve months. Its own GF Value of $579.19 is labelled a possible value trap by the same publisher.

Sezzle jumps 9.7% with no news attached

Sezzle rose 9.7% to close at $128.64, inside a 52-week range of $49.50 to $195.71, on volume of 669,317 against a 620,915 average. None of the three items explains why. A Form 144 was filed for 10 October, GuruFocus puts GF Value at $95.31 (a 35% premium to the current price) with a GF Score of 81/100 and insider net selling of $26.7m over the past year, and TD Cowen maintained Buy on 6 October while trimming its target from $165 to $160. Earnings are dated 4 November.

Datadog hits an all-time high

Datadog gained 7.1% to $293.26, an all-time high, taking market cap to about $105bn and year-to-date return to roughly 101%. CIBC's Todd Coupland maintained Outperformer and raised his target from $280 to $315. That sits alongside a thick run of recent coverage: Yorkville Ives at $335, FBN Securities at $325, Wedbush at $275, Mizuho at $300 and Stifel at $305, with Wedbush citing revenue growth accelerating to 36% year-over-year in fiscal Q2 2026 and Stifel pointing to OpenAI's spend with Datadog, around $80-85m a quarter in FY25 and into the low $100m range in Q2 2026. Against that, insider selling is heavy: CTO Alexis Le-Quoc sold 53,912 Class A shares for $14.75m on 7 October under a 10b5-1 plan set up in June 2025, leaving him with 488,033 shares directly, and GuruFocus counts $913.5m of insider sales over twelve months with no purchases. GF Value is $205.66, making the stock 42.6% overvalued on that measure, with a GF Score of 84/100 and a trailing P/E of 598.5x against a five-year median of 418.9x.

Joby downgraded, hits 52-week low

Joby Aviation is down 5.4%, hitting a 52-week low of $5.57. The headlines state Barclays downgraded it to Underweight and cut its price target to $4. That's all these items say; no further detail was read.

Teva FDA approval, Oracle rebound

Teva is up 4.7% on headlines reporting FDA approval of Weltruza, a once-monthly injectable antipsychotic for schizophrenia. Oracle rose 4.6% with a cluster of headline-only items pointing in several directions: an insider purchase described as $3.5m, renewed scrutiny of OpenAI metrics alongside Microsoft, and several chart pieces around the $141-144 area. GuruFocus notes a GF Value of $194.91 against a price of $141.40. Nothing here was read in full.

The SpaceX spectrum deal running underneath everything

The single connecting thread across the section is SpaceX's roughly $8bn acquisition of a nationwide low-band spectrum portfolio from Grain Management, priced in one headline at $571m per MHz. That's the same event sitting behind the ASTS drop, and headline-only items show it knocked AT&T, Verizon and T-Mobile lower while lifting tower REITs, with options desks active in all three telecoms. Barclays initiated SpaceX at Overweight and TD Cowen reiterated Buy with a $200 target; Barclays also initiated Rocket Lab at Overweight, while TD Cowen cut its RKLB target to $90. Separately, Venezuela authorised Starlink to operate nationwide, and Musk publicly accused Ambani of blocking Starlink in India, which India rejected. SPCX itself was up only 1.2%.

Apple soft on iPhone 18 Pro order reports

Apple is down 1.1% against a heavy but headline-only news flow, the recurring item being reported order cuts to the iPhone 18 Pro on demand concerns, with suppliers named as affected. Evercore ISI reiterated its rating citing iPhone lead times. Other headlines flag a touchscreen MacBook and iPad mini refresh said to be coming 27 October, and an expanded $212m China clean energy fund.

The rest of the list

Everything else is small moves and routine filings. CRSP +5.8% on ARK buying while selling DraftKings, VDTA +5.6% on Form 4s, NIO +5.0% with a "why is it surging" headline that wasn't read, FJET -4.8% on an 8-K covering bylaw amendments. Mid-single-digit gainers with analyst or score headlines only: Xometry, Dave, AngloGold, AMC, Coherent and Itau, On Holding, Arista. Coherent's move is tied to Lumentum's CEO reportedly saying AI components are sold out through 2029. Netflix is down 1.8% on reports via Puck News that it plans to cut 5% of its workforce. Astera Labs slipped 1.4% after a Northland downgrade on valuation. Micron, Broadcom, Costco, Accenture and the remaining names moved less than 1% on filings and target tweaks.

Veea jumps on governance fix

VEEA is the biggest mover on the list, up 47.3%. Veea said on October 8 that it resolved all outstanding Nasdaq corporate governance deficiencies: Alan Black was added to the Compensation Committee, Kanishka Roy to the Audit Committee, and board member Helder Antunes resigned to restore an independent-director majority, though he stays on as executive VP and chief revenue officer. The GuruFocus piece pairs that with a hard look at the fundamentals behind a $12 million market cap: price-to-sales of 19.2 against a historical median near 109, trailing EPS of -2.80, a GF Score of 4 out of 100, financial strength rated 1 out of 10, an Altman Z-Score of -11.69, and no insider buying in the past twelve months. So the catalyst is a listing-compliance fix, not an operating change.

AST SpaceMobile at a 52-week low

ASTS is down 10.5% and traded to a fresh 52-week low, below the prior $49.31 mark, leaving it roughly 61% under its $133.86 high. The driver is SpaceX: the FCC authorized SpaceX to build a 15,000-satellite direct-to-cell network using its own spectrum, which bypasses the carrier relationships AST's model depends on. On top of that, the FCC's October 29 agenda came out a day early and includes a proposal to auction 25 MHz in bands usable for direct-to-device, which Clear Street called a mixed signal while keeping its Buy. The stock was already carrying a B. Riley downgrade to Neutral with a $65 target from October 2, a William Blair cut to its 2027 revenue estimate from $752 million to $459 million on launch delays, six straight earnings misses, a $125.9 million write-off on the BlueBird 7 failure, and a $1 billion convertible that pushed the 45-satellite target into early 2027. Roth MKM kept Buy at $108. One TradingView note cites Q2 2026 revenue of $31.5 million against a $230.9 million net loss, pro forma liquidity above $3.7 billion, and FY2026 guidance of $150-200 million.

The other side of the ASTS story

Two GuruFocus pieces on the same name read the SpaceX news the other way. Berenberg's Michael Filatov reaffirmed Buy, arguing the pending FCC approval of Grain Management's nationwide spectrum sale to SpaceX makes AST more relevant as the carrier-aligned satellite partner. Separately, AST's CEO pointed out that its domestic telecom partners hold roughly 1,000 MHz of low and mid-band spectrum that its constellation can use, plus its own 45 MHz L-band allocation, targeting peak speeds near 200 Mbps. Both notes flag the same uncomfortable numbers: price-to-sales around 120 versus a 62 median, GF Score 44 out of 100, profitability 1 out of 10, and insiders selling $451.6 million of stock over twelve months against $0.8 million bought. Options flow Friday was 253,920 contracts, 158,506 calls to 95,414 puts, with heavy fresh call buying at the Oct 16 $50 and $55 strikes and the single largest contract being the Jan 2027 $50 put at 10,372. Three-month implied vol rose 4.55 points to 81.3%.

SpaceX spectrum deal rippling across telecom

The same event sits behind a large cluster of headline-only items. SpaceX is up 1.2% after announcing an $8 billion acquisition of a nationwide low-band spectrum portfolio (reported elsewhere as 800 MHz from Grain Management), and the headlines describe telecom stocks falling on it in both the US and Europe, with Deutsche Telekom off 7%. The Investing.com market-mover tables in several of these articles show T-Mobile -13.3%, AT&T -9.9% and Verizon -8.8%, while tower names rallied, Crown Castle +15.6%, American Tower +9.3% and SBA +7.3%, with Goldman calling the deal a positive for US towers. Barclays initiated SpaceX at Overweight and TD Cowen reiterated Buy with a $200 target. There is also a separate Musk-versus-Ambani spat over Starlink's India launch, which India has publicly rejected as a monopoly claim.

Sezzle and Datadog lead the upside

SEZL is up 9.7%, closing near $129 on volume slightly below its 20-day average, with the Yahoo quote page showing a 52-week range of $49.50 to $195.71, trailing P/E of 28.1, revenue of $531.9 million and a TD Cowen note from October 6 that maintained Buy while trimming its target from $165 to $160. DDOG is up 7.1% at an all-time high of $292.80, a $105 billion market cap and a 101% year-to-date return. The supporting detail: 80% gross margin, revenue growth that accelerated to 36% year-over-year in fiscal Q2 2026 from 28% the prior quarter per Wedbush, and a Stifel estimate that OpenAI's spend with Datadog hit the low $100 million range in Q2. CIBC raised its target to $315 on Friday; Yorkville Ives, FBN and Wedbush have initiated at Outperform with $335, $325 and $275.

Joby at a 52-week low on a Barclays cut and a jury verdict

JOBY is down 5.5%, touching a 52-week low near $5.39 against an $18.77 high, down about 65% over the year. Barclays moved it from Equal Weight to Underweight and cut the target from $6 to $4, questioning whether any single player can own the eVTOL market, whether Joby's aircraft meets broad payload requirements, and whether its plan to vertically integrate manufacturing, operations and servicing is realistic at its current scale. Still unresolved is a $116.9 million jury verdict in Tampa federal court awarding Aerosonic damages for breach of an NDA and misappropriation of trade secrets on air data probes, including exemplary damages for willful conduct; Joby disputes it and plans post-trial motions and appeal. A director also filed a Form 144 this month. On the other side, Q2 revenue was $38.6 million versus $24.2 million in Q1, with Blade contributing $36.2 million, and Joby has agreed to buy defense firm Resonant Sciences for about $500 million. H.C. Wainwright keeps Buy at $18; Cantor is Neutral. Insiders sold $52.8 million over twelve months with no buying.

Two Form 4 filings with no content behind them

OPNW is down 17% and VDTA up 6.8%, and in both cases the only item is a bare Form 4 filing notice (VerifyMe and Vertical Data respectively) with no transaction detail in the article at all. Neither piece explains the move, so if either position matters to you, the filing itself is where to look.

Oracle, Teva and the optics names

Oracle is up 4.7% on a thick run of headline-only items: a rally story, an insider buying $3.5 million of stock, a dividend piece, a data center growth forecast, and separate headlines about OpenAI metrics coming under scrutiny for Oracle and Microsoft. Teva is up 4.6%, with headlines stating FDA approval of Weltruza, a once-monthly injectable antipsychotic for schizophrenia, alongside a conference call transcript. Coherent is up 3.4%, with headlines attributing the move in optical networking names to Lumentum CEO comments that AI components are sold out through 2029. These are headlines only, so take them as what was stated, not as reported detail.

Apple soft on iPhone 18 Pro order cuts

AAPL is down 1.1%, and the headline cluster is consistent: Nikkei Asia reported Apple cutting iPhone 18 Pro component orders on sluggish demand, with one headline also tying production cuts to surging memory chip prices. Separate headlines flag an October 27 event with a touchscreen MacBook and M6 chip models, and Evercore ISI reiterating its rating on iPhone lead times. All headline-only.

The quiet rest

Nothing else on the list carries much. NIO is up 5.3% on a headline that asks why it is surging without answering in the title. Astera Labs is down 1.4% on a Northland downgrade on valuation. Netflix is off 1.8% with headlines about a reported 5% workforce cut (Puck News) and a Morgan Stanley target revision. TSMC is down 1.0% despite headlines citing a 55% September sales surge and a Q3 revenue beat. Rocket Lab is flat with a Barclays initiation at Overweight and a TD Cowen target cut to $90. The remainder is ETF flow notes, routine analyst reiterations and chart posts.

Veea down 17.8% despite a governance-fix headline

Veea is the biggest mover on the list, down 17.8%, which sits oddly against the GuruFocus piece carried here. That article, dated October 8, describes a 49% after-hours jump after the company resolved all its Nasdaq listing compliance problems: Alan Black was added to the Compensation Committee, Kanishka Roy to the Audit Committee, and board member Helder Antunes resigned so independent directors would hold a majority, though he stays on as executive VP and chief revenue officer. The rest of the piece is unflattering. Market cap is $12 million, the GF Score is 4 out of 100 with financial strength at 1/10, trailing EPS is -2.8, the Altman Z-Score is -11.69, and there has been no insider buying. Price-to-sales is 19.19 against a historical median of about 109. So the after-hours pop the article describes and today's quote point in opposite directions; the article offers no reason for the reversal.

Coherent down 9.6% with two conflicting stories

Coherent is down 9.6%, and the watchlist carries two pieces that disagree. The Investing.com article, published the morning of October 9, explains a 3.5% pre-open rise: Lumentum's CEO said AI data centre demand has booked out its optical component capacity through early 2029, which the market read across to Coherent's own order book and pricing. It cites Coherent's PhotonLink platform launched in September 2026 and a TrendForce forecast of a 650 million unit VCSEL market by 2031 at a 38% CAGR, with Applied Optoelectronics and MaxLinear also higher pre-market. The GuruFocus piece covers the other side, the actual 9.6% fall on October 8 to $302.35, against a GF Value of $102.99, a GF Score of 78/100 with valuation ranked 1/10 and momentum 9/10, a 73.5x P/E versus a 78.0x five-year median, and $1,117 million of insider selling over twelve months with no buying. Worth noting Lumentum itself closed down 5.62% on the quote tables in those same pages.

Astera Labs down 9.2% on a Northland downgrade

Astera Labs fell 9.2%. Northland's Gus Richard cut it to Market Perform from Outperform purely on valuation, with the stock at $347.05 on a P/E of 172. His prior $350 target was built on 50 times a calendar 2028 estimate of $5.00, and he says $5 is achievable but not a given, while expecting estimates to rise over the next couple of quarters as Scorpio-X ramps. The companion Investing.com explainer adds that Zacks had already moved to Hold from Strong Buy the day before, and an October 8 Form 144 flagged a potential insider sale on top of an existing pattern of selling. Context from that piece: Q2 2026 revenue was a record $392.4 million, up 104%, with EPS of $0.80 against $0.69 expected, and Needham had raised its target to $425 from $260. Q3 earnings are due November 3. Separately, Goldman's equal-weight ETF GSEW trimmed 4,862 ALAB shares worth $1.9 million on October 7, part of net selling of $33.6 million that day; the same fund holds ASTS and COHR at 0.21% each.

Nebius down 7.4% ahead of October 22 earnings

Nebius is down 7.4%. Rosenblatt's John McPeek initiated with Buy and a $304 target against a $237.15 close, modelling 4.25 to 4.75 gigawatts of operational compute by 2030 and a 98% revenue CAGR from FY2026 to FY2030. The Investing.com preview frames the October 22 release: Q2 revenue was $582.3 million, up 454%, with AI-cloud revenue up 514%, and the last quarter beat EPS estimates by 80.78% with a 31.99% post-earnings move. The bear side is execution and financing, specifically power connection, equipment and construction delays pushing out payback, against 18.5x forward EV/Sales and 44.3x forward EV/EBITDA. Technically the piece notes price below all daily moving averages but still above the weekly 50, 100 and 200.

Revolution Medicines down 6.3% on FDA subgroup data

Revolution Medicines fell 6.3% after FDA review documents questioned how daraxonrasib, the approved RASONQUE therapy, performs across KRAS mutation subtypes. The numbers: 32% overall response rate, driven by 50% in G12V, versus 24% in G12D, which is the largest cohort at 43% of patients. The FDA stressed the analyses were not designed for formal subgroup comparisons. Four separate pieces here push back. TD Cowen's Tyler Van Buren kept Buy, arguing the 24% G12D figure is close enough to the 31% ITT rate and that PFS and OS hazard ratios are consistent across mutation types, with Zoldon the leading G12D inhibitor in development. RBC kept Outperform and raised its target to $259 from $251. Truist called the dip an entry point. Stifel, cited in the GuruFocus piece, is the one suggesting biology may genuinely limit efficacy in G12D. On the ownership side: no insider buying in twelve months against $149.7 million of insider selling, 109 sales and zero purchases over six months, while 10 gurus hold with 7 adding and 5 trimming. GF Score is 27/100. The stock touched an intraday low of $180.52 against a 52-week low of $47.28, with the next earnings in November.

AST SpaceMobile down 6.1% at the $55 line

ASTS fell 6.1% to close at $56.93 with an intraday low of $55.96 on roughly 19.2 million shares. Both TradingView pieces here are technical and both name the same levels. Robert_V12 had flagged $55 three weeks ago after the $75 rejection and now watches whether buyers defend it, with $50-52 next and $45 then $40-42 if that goes, and $60-65 as the recovery confirmation zone. He ties the pressure to SpaceX agreeing to buy 800 MHz of spectrum from Grain Management, which adds a better-funded competitor in direct-to-device, while arguing the AT&T and Verizon relationships may become more valuable as a result. Tesi_Daniela_Radice adds the operating detail: BlueBird launches 8-10 in June and 11-13 in August, a target of roughly 45 satellites by early 2027, 60-plus operator partners, Q2 2026 revenue of $31.5 million against a $230.9 million net loss including a large non-cash charge, pro forma liquidity above $3.7 billion, and FY2026 guidance of $150-200 million. Two further headline-only items on the list say the same thing about $55 being tested.

SpaceX spectrum deal is the day's shared driver

The SpaceX item is the biggest single cluster on the list and it connects to ASTS and to the telecom names. Headlines only, so taking them at face value: SpaceX is acquiring roughly $8 billion of low-band 800 MHz spectrum to enable Starlink Mobile, Musk posted that it is the last critical piece needed to provide complete phone coverage in America, and US and European telecom stocks sold off, with Deutsche Telekom reported down 7%. Goldman is said to see it as positive for US tower stocks, which rose. SPCX itself is down 4.2%. Other headlines in the group cover Banglalink launching Starlink service in Bangladesh, American Airlines equipping over 1,000 aircraft with Starlink Wi-Fi, Musk criticising Mukesh Ambani over Indian delays, and Trump disclosing SpaceX bond purchases.

Oracle down 5.5% on OpenAI revenue reports and power workarounds

Oracle is down 5.5%, described in one headline as its biggest one-day drop in twelve weeks. The cluster is headline-only but consistent: reports on OpenAI's revenue hit Oracle and Microsoft, analysts warned of revenue risk from project delays, and Oracle is trucking natural gas to power data centres in Utah and Texas to get around pipeline delays, with the same approach possibly extended to a 2.45-GW project. Bloom Energy shares reportedly fell on that gas report. One headline puts Oracle's price at $135.69 against a GF Value of $194.75, and another says Michael Burry has flagged a concern.

The rest of the AI complex lower

Broadcom is down 4.3% with no single explanation in the headlines, though one notes it fell despite TSMC's record AI quarter and another references controversy over circular financing tied to its capital raise. TSMC itself is down 3.0% despite headlines pointing to a record NT$1.49 trillion quarter. Also lower without substance behind the lines here: TeraWulf down 5.2% with calls reportedly outpacing puts four to one, Micron down 4.8%, NuScale down 4.6% at a 52-week low of $7.21, Nokia down 4.5% crossing below its 200-day, Rocket Lab and SPCX in the same Rocket Lab headline, Modine down 4.0%, Credo down 3.7% on a Form 144, and CRISPR down 3.6%.

Gainers are thin and mostly unexplained

VerifyMe is up 10.3%, but the only item attached is a Form 4 filing and the article text is pure site boilerplate with nothing on the filing itself. Marathon Petroleum is up 4.8% alongside headlines on refining and E&P sector leadership. Netflix is up 2.7%, with one headline reporting plans to cut 5% of its workforce per Puck News and another noting Morgan Stanley trimmed its target. Take-Two up 2.6%, Dave up 2.5%, Aflac up 2.0% on a Japan Post share sale, Sezzle up 3.0% on an 8-K with results.

Apple barely moved despite the volume of coverage

Apple is up 1.1% on by far the longest headline list here, which is mostly noise. The items with actual content are a reported cut to iPhone 18 Pro component orders on soft demand per Nikkei, an October 13 "Welcome Home" product event in Tribeca expected to centre on smart home, Steve Smith named head of M&A, an SVP share sale of $796,491, and PC shipments down 20.1% in Q3 with Apple gaining share. Nothing here moved the stock much.

Everything else quiet

The remainder is routine: analyst target tweaks on Amphenol, Axsome, Exelixis, Wheaton and Kodiak Gas, ETF flow reports, Mercury Systems adding 50,000 square feet in Phoenix, a Butterfly Network CEO sale of 35,790 shares, and Costco edging up 0.6% despite September sales reported up 13%. None of it needs a second look today.

The day's shape: AI complex sold off

Almost everything that fell hard on your list fell together, and the backdrop from the Investing.com pages is the same across them: the Nasdaq dropped 1.25% on a report that OpenAI's annualized revenue is less than previously shown, while the Dow finished up 0.10% and the S&P 500 off 0.47%. Oil was the other big mover, WTI up 3.32% around $91 with Brent near $104, and the 10-year sat at 5.22%. So the optics-and-compute names, the neoclouds and the power plays all got hit at once, while the refiner on your list was the best performer of the day. Note that none of the single-stock articles below attributes the drops to company news except where I say so.

Coherent down 9.5% with no stated cause

COHR was the worst mover, down 9.5%. The Yahoo page shows it closing at $302.02, off $32.54 from a $334.56 prior close, with a day's range of $298.89 to $328.87 and volume of 8.37 million against a 6.36 million average. The alert flags it as roughly 1.6 times its own ATR20 on about average volume. Nothing in the three COHR items explains why: the Yahoo page is a quote page, the Investing.com item is a bare Form 4 insider filing notice dated 7 October with no detail attached, and the TradingView post is a chart note watching for a weekly close above a horizontal line. Worth remembering the stock is still up 63.9% year to date and 159% over a year, with a $412.52 average analyst target and a Bernstein initiation at Outperform, $350, on 30 September.

Astera Labs and a Form 144

ALAB fell 9.2%. The only ALAB-specific item with any substance is a Form 144 notice filed 8 October, which is a notice of intent to sell restricted stock. The Investing.com page carries nothing beyond the filing title, so I can't tell you size or seller. The other ALAB item is the same chart-watcher's breakout note, no news content.

Tower Semiconductor and Ur-Energy

TSEM was down 8.4%, closing at $228.59, a $19.66 drop from $248.25, on about 2.05 million shares against a 1.88 million average. Again no reason given in the material. It remains up 89% year to date and 217% over twelve months, with Mizuho having initiated at Outperform with a $300 target on 25 September. URG fell 8.2% to $1.005, which is its 52-week low, and this one is not an AI-selloff story: it's down 27% over a month and 45% over a year, with RBC having maintained Outperform back in August while cutting the target from $1.75 to $1.60. No news item here explains today's move either.

Nebius hit 7.2% despite a new Buy initiation

NBIS fell 7.2% even as Rosenblatt Securities started coverage at Buy with a $304 target, which was about 28% above the $237.15 price at the time. Rosenblatt's case is capacity: Nebius has 3.5GW of contracted power with 75% expected to come online at fully owned sites, putting it roughly one-sixth the size of CoreWeave's 1.5GW of active revenue-generating power. They model Q2 2026 revenue up 5.5 times year over year, full-year 2026 up 6.5 times, and a 98% revenue CAGR through FY2030, with the $304 target built on a ten-year DCF at a 12% discount rate and a 12x terminal free cash flow multiple. They also expect more debt or equity to fund the buildout, after the $5.75 billion convertible in August. Context from the other items: Truist is at Buy with $355, DA Davidson raised to $250 from $175 after the Vineland data center approval, insiders have sold $161.35 million in three months, and the Investing.com preview puts earnings on 22 October, with the bear case resting on capacity delays into H2 2026 and 2027, financing dilution, and 18.5x forward EV/Sales.

Revolution Medicines on an FDA review

RVMD was down 6.3%, and this one does have a clear cause. An FDA review published today questioned daraxonrasib's efficacy across KRAS mutation subtypes, with the regulatory documents noting the underlying analyses were not designed for formal subgroup comparisons. The numbers from GuruFocus: a 32% overall response rate, but 50% in the G12V subgroup versus 24% in G12D, which is the largest cohort at 43% of patients. Stifel points to biological complexity in G12D as a possible explanation. The drug, marketed as RASONQUE, only got its FDA approval for previously treated metastatic pancreatic cancer in late August. Two analysts raised targets into the drop anyway: RBC to $259 from $251 at Outperform, Truist to $240 from $239 at Buy. Insiders have logged 109 sales and no purchases in six months. Intraday low was $180.52.

Vicor and the valuation note

VICR fell 7.2% today. The GuruFocus piece is actually about yesterday's 5.5% decline to $282.78 and is a valuation argument rather than news: GF Value of $71.32 against the market price, a trailing P/E of 90.8x versus a five-year median of 74.2x, and $424.1 million of insider selling over twelve months with no buying. No fresh company event in the material.

Oracle's power workaround and the AI debt pile

ORCL was down 5.9%, described in one headline as its biggest one-day drop in twelve weeks. The headline cluster, which I have not read in full, says Oracle is trucking natural gas to power AI data centers to get around pipeline delays, already doing so in Utah and Texas with the approach possibly extending to its 2.45GW Project, and that Bloom Energy shares fell on that report. Separately, a WSJ-sourced headline has Oracle, Broadcom and SpaceX all pursuing large debt deals to fund the AI buildout, with Broadcom specifically working to arrange more than $50 billion for OpenAI chips. AVGO itself was off 4.4%, with another headline noting Marvell raising the stakes in custom chips. Mizuho added Oracle to its Top Picks list the same day.

SpaceX headlines, mostly Starlink

SPCX fell 4.1% against a heavy run of headlines, all headline-only here: Musk accusing "certain oligarchs" of blocking Starlink's India launch, American Airlines extending Starlink Wi-Fi to its entire mainline fleet of over 1,000 aircraft, Erste Group initiating at hold, a reported $40 billion financing effort with Apollo, and a disclosure that Trump bought SpaceX debt in August.

TSMC fell on strong numbers

TSM was down 3.1% despite headlines reporting September revenue growth of 54.6%, a record Q3 above $46 billion, and a Citi target of NT$4,000. Several of the headlines make the point explicitly, that the sales beat and the share fall happened together.

The green side: refining and a Generac upgrade

MPC was the largest gainer at 4.8%, consistent with the oil move, and the headlines put refining and E&P at the top of the sector leaderboard with Mizuho raising its MPC target to $457. Elsewhere on the plus side, Generac rose 1.0% on a Keybanc upgrade to Overweight with a $280 target and a Piper Sandler initiation at Overweight, $303, with one headline tying it to AI data center demand. Apple added 1.1% ahead of a 13 October "Welcome Home" product event in New York and the appointment of Steve Smith as M&A chief. IOVA was up 3.4% on a Baird target raise to $11, and Netflix gained 2.7% even as Morgan Stanley and Barclays both trimmed targets.

Smaller and quiet names

ASTS fell 6.1%; the only item is a TradingView speculative long note keyed off the $55 to $56 support zone, not news. WULF was down 5.2%, SMR hit a 52-week low of $7.21, RKLB fell 4.6%, and the rest of the list, AAPL ETF-flow items, NIO, APH, COST, AMC and the various single-line analyst notes, carries nothing beyond what the headlines state. One oddity: an item tagged CAN at -6.0% is actually a Walter Bloomberg post quoting CBO's Swagel saying growth alone is unlikely to stabilize the debt trajectory, which has nothing to do with the ticker.

Surf Air down hard against good operating news

Surf Air Mobility was the biggest mover on the list, down 9.6%, and the only news item attached to it reads positively. The company said its SurfOS software helped cut direct operating cost per block hour by 6% and fuel burn per block hour by 9% year-to-date in 2026, with pilot cost per block hour down 9% and labour productivity per block hour up 15%. Q2 ended with a 98% controllable completion factor and 88% on-time arrivals, and Mokulele in Hawaii grew revenue about 7% year over year. It also won a four-year Essential Air Service contract from the DOT covering Lanai through August 2030, worth $19.4 million in subsidies excluding fares and double the term of the prior deal. Other items: 64 demonstration flights of BETA's ALIA CTOL across four Hawaiian islands with Hawaiian Airlines support, joining the FAA's advanced aviation consortium and its airspace trajectory initiative, a Safety Management System finished ahead of the Part 135 deadline, and the Kona–Kahului route relaunched for the first time since 2023. The release gives no explanation for the share move.

Macro backdrop driving the risk-off names

The common thread under most of today's declines is in the Rocket Lab piece, which was explicit that the 4.2% fall had no company-specific cause. It pinned the move on rising Treasury yields, higher oil, and caution ahead of the Fed's September minutes, with the S&P off 0.6%, Dow down 1.0% and Nasdaq down 0.8% intraday. It also noted RKLB had run roughly 17% over the prior month on a record 20-launch Electron contract with Japan's Synspective and a Citi Buy with a $105 target, so part of this is consolidation after a strong run, with execution demands across the Iridium acquisition and Neutron development still ahead. Sector sentiment was further weighed by reports SpaceX is seeking a $40 billion financing package. On the geopolitics, two Walter Bloomberg posts relaying a senior Iranian official to Reuters said Iran will never give up its right to enrich though enrichment details can be discussed later, and that there have been no negotiations with the US, with Tehran's conditions needing to be met first. Separately, Italy's economy minister asked the EU to treat inflation as a factor justifying deviation from budget goals. Those three X items carry a -4.4% quote tag against the ticker CAN, which looks like a tagging artefact rather than a reaction in that name.

The GuruFocus overvaluation template across five holdings

A cluster of automated GuruFocus pieces hit five of your names with the same structure, so read them as one screen output rather than five independent views. Navitas was down 5.6%, with the article citing a 3.0% decline to $11.97 against a GF Value of $2.99, a GF Score of 63, momentum ranked 8/10 and valuation 1/10, and $150.7 million of insider selling over twelve months with no buying. Vicor fell 5.5% to $282.78 versus a GF Value of $71.32, GF Score 79, trailing P/E of 90.8x against a five-year median of 74.2x, and $424.1 million of insider sales with no purchases. Rocket Lab, down 4.2% at $71.92, carries a GF Value of $38.89, a score of 71 with growth at 10/10 and valuation at 1/10, and $683.3 million of insider selling. TeraWulf fell 3.8% to $14.40 against a GF Value of $5.86, with the weakest scorecard of the group at 39/100 and net insider selling of $35.6 million. Anglogold Ashanti (down 3.7%) and Mercury Systems (also down 3.7%) appear as headline-only versions of the same template, quoting GF Value of $65.85 against $90.05 and $48.60 against $79.75 respectively.

Nebius slides on a buy initiation

Nebius was down 5.1% on the day Rosenblatt Securities started coverage at buy with a $304 target, about 28% above the $237.15 price. Rosenblatt places Nebius near the top of the neocloud group alongside CoreWeave, estimating its active revenue-generating power at roughly one-sixth of CoreWeave's 1.5GW, with 3.5GW contracted and 75% expected to come online at fully owned sites. Q2 2026 revenue was up 5.5 times year over year, full-year 2026 is expected up 6.5 times, and the firm models a 98% revenue CAGR through FY2030, with the target built off a ten-year DCF at a 12% discount rate and a 12x terminal FCF multiple. It expects more debt or equity to fund capacity, after August's $5.75 billion convertible. The same piece lists Truist initiating at buy with a $355 target, DA Davidson lifting to $250 from $175 on the Vineland data centre approval while keeping a Neutral, a planned $4.5 billion convertible note offering due 2030 and 2034, and October price rises on on-demand H100, H200, B200 and B300 GPU capacity. A separate GuruFocus daily brief flags COO Ophir Nave selling 500,000 shares at $235.53, about $117.8 million, on 6 October.

Micron up on conflicting inputs

Micron rose 4.1% to $1,088, the largest gainer here, and the four items on it pull in different directions. DA Davidson raised its price target to $3,000 from $2,100, citing memory demand from AI accelerators and data centres, though the stock was actually down 2.6% premarket at $1,018 when that piece ran. Against that, union members at Micron's Taiwan operation voted 99% in favour of authorising a strike over bonus structure, demanding a permanent profit-sharing plan allocating 15% of operating profits to quarterly bonuses, which comes with memory prices already climbing on supply shortage. The GuruFocus valuation note gives Micron a GF Score of 90 with growth 10/10 and profitability 9/10, a trailing P/E of 14.7x versus a five-year median of 20.7x, but a GF Value of $764.61 against the market price, and net insider selling of $373.2 million. ETFs were net sellers of $97.0 million on 5 October, led by SPY at $66.1 million, QQQ $57.7 million and IVV $45.3 million, though 43 funds bought versus 24 sold. Trailing twelve-month revenue is given as $133.19 billion, up 250.7%, with the stock up 266.55% year to date.

Brazilian financials downgraded by HSBC

Itau Unibanco fell 4.0% after HSBC's Carlos Gomez-Lopez cut it from Buy to Hold with a $9.10 target against a $9.74 price. The accompanying GuruFocus data puts GF Value at $5.48, a GF Score of 70 with profitability and growth both 8/10 but financial strength at 2/10 and valuation 1/10, a P/E of 13.13x versus a five-year median of 7.9x, a 5.84% dividend yield, and $1.12 million of insider selling over three months. Bradesco, down 3.8%, has a headline-only item saying HSBC also downgraded it with a $3.90 target, so this looks like a single HSBC sector action rather than two separate calls. Separately, a headline notes Itau BBA upgraded XP to Outperform.

NetApp upgraded

NetApp was up 3.2% on a cluster of headline-only items all pointing at the same thing: Evercore ISI upgraded the stock with a price target raised to $300, cited as based on the FY27 growth outlook. Investor's Business Daily and Investing.com both carried it, and a GuruFocus headline asks whether the stock is overvalued after the rally.

SpaceX and the AI debt wave

SpaceX was down 2.5% with by far the heaviest headline flow of any name here, though none of it was read in full. The dominant story is a reported $40 billion financing effort, led by Apollo Global Management per one headline, to fund Nvidia chip purchases for computing infrastructure, first reported by the FT. Susquehanna raised its target to $173 from $144. There is a parallel set of Musk posts on Starlink: availability in Bangladesh, accusations that "certain oligarchs" are blocking the India launch, a denial that Starlink beams were used over India since they are turned off there, and claims that V2 direct-to-cell satellites will carry over 100 times the bandwidth of V1. Other headlines cover a 32-mile Florida natural gas pipeline application, Cathie Wood trimming the position, Musk saying TSMC will not be involved in operating the Texas Terafab, and a reported science medal from Trump. This connects to Broadcom, up 0.2%, where headlines say it is arranging more than $50 billion tied to the OpenAI chip programme, and Oracle, down 0.8%, with the WSJ reporting all three chasing large debt deals to fund AI buildout. Oracle separately appears on Mizuho's Top Picks list and drew an In Line initiation from Yorkville's Dan Ives on execution risk.

TSMC and the rest of semis

TSMC fell 2.1% despite headlines saying it beat its September sales target with revenue up 54.6% and posted record Q3 revenue above $46 billion, with Citi raising its target and projecting over 40% revenue growth by 2027. Elsewhere in chips, Astera Labs was down 1.9% with a Form 144 filing and an unread "why is it sliding" piece, Sandisk was up 1.9%, Amphenol down 1.2% with UBS raising its target to $105 and a leadership change in its harsh environment division, and Coherent down 1.1%.

Quieter names

Apple rose 0.9% amid heavy but low-content ETF flow coverage, plus headlines on a European Commission proposal to tax large US tech firms, a smart home launch with LG, and a $400 target tied to Siri. Elsewhere: TD Synnex, down 2.5%, agreed to acquire specialty distributor BlueStar; Generac, down 1.0%, was upgraded to Overweight by KeyBanc with a $280 target and initiated Overweight at Piper Sandler, alongside an insider sale; SoundHound, down 1.6%, hit a 52-week low at $5.64; Datadog, Netflix, Aflac, Costco, Joby and Credo all carry routine analyst or filing items with moves under 2.5% and nothing substantive behind them.

Surf Air leads the downside despite good news

Surf Air Mobility is down 9.9%, which sits oddly against what it actually announced. The company said SurfOS software drove a 6% cut in direct operating cost per block hour and a 9% cut in fuel burn per block hour year to date in 2026, plus a 9% drop in pilot cost per block hour and a 15% gain in labour productivity. Q2 ended with a 98% controllable completion factor and 88% on-time arrivals, and Mokulele in Hawaii grew revenue about 7% year over year. It also won a four-year Essential Air Service contract from the DOT covering Lanai through August 2030, worth $19.4 million in subsidies excluding fares, double the term of the prior deal. Other items: 64 demonstration flights with BETA Technologies' ALIA CTOL aircraft across four Hawaiian islands with Hawaiian Airlines' support, first Part 135 passenger operator into the FAA's Center for Advanced Aviation Technologies Consortium, a Safety Management System implemented ahead of the FAA deadline, and Kona–Kahului service relaunched for the first time since 2023. The article gives no reason for the share price fall.

BeyondSpring 8-K

BeyondSpring is down 8.9% with an 8-K on EDGAR reporting completion of an acquisition or disposition of assets. Headline only, so no detail on what was bought or sold.

Navitas closes Claros, shares fall anyway

Navitas is down 5.8% on the day it confirmed closing the Claros acquisition. Claros builds integrated voltage regulator technology for AI data centres, combining power transistors, digital control, inductors and capacitors, with a PowerArray architecture meant to move power conversion closer to the processor. Navitas says the deal takes its serviceable addressable market past $8 billion by 2030, adding at least $3.5 billion from vertical power delivery and IVR on top of its existing $3.5 billion GaN and SiC base and roughly $1 billion from JFET. CEO Chris Allexandre called it a defining step in the "Navitas 2.0" transformation. A webinar on the technology is set for 20 October. A separate 8-K (Reg FD, Other Events) and a GuruFocus piece on the same acquisition round out the cluster, along with a GF Score note. Again, nothing in the material explains the drop.

Nebius down with insider selling and chart chatter

Nebius is off 5.1%. Two GuruFocus headlines say COO Ophir Nave sold 500,000 shares on 5 October, described as nearly half his holding. The rest of the NBIS flow is retail chart commentary on TradingView rather than news: one poster expects a retrace but not below $205, another says he went short despite a clean upside break of the consolidation because momentum and volume lagged, and a third thinks $250 resistance is likely to give way. Treat these as opinion, not information.

A PL tagging problem

The ticker PL is down 4.4%, but the full-text item filed against it is an earnings call for Progressive Planet Solutions (PLAN), a different company, not Planet Labs. For what it's worth, Progressive Planet posted record fiscal Q1 2027 revenue of CAD 7.3 million, up 12.1% from CAD 6.51 million, with roughly 400 basis points of margin compression from freight, diesel and packaging inflation. Freight alone rose 50.5% to CAD 1.233 million. CEO Stephen Harpur said he doesn't expect meaningful margin improvement over the next six to twelve months. The only genuine Planet Labs item is a GuruFocus GF Score note referencing a 7.0% share surge, which conflicts with today's quote.

Macro headlines mistagged to CAN

CAN shows down 4.3%, but the items under it are macro wire posts, not company news. A senior Iranian official told Reuters that Iran will never give up its right to enrich though enrichment details can be discussed later, and separately that there have been no negotiations with the US and that Washington must meet Tehran's conditions first. Italy's economy minister asked the EU to treat inflation as a factor justifying deviation from budget goals. A headline-only item has Zelenskiy citing updated intelligence that Russia is preparing a massive attack. Relevant to oil and yields, not to CAN itself.

Rocket Lab, ITUB, VEEA

Rocket Lab is down 4.2%, with Investing.com running a "why is the stock sliding today" piece and a bearish TradingView head-and-shoulders post, both headline only. Itau BBA upgraded XP to Outperform from Market Perform, per a headline tagged to ITUB, which is down 4.3%. Veea has an 8-K with only an Other Events item, down 4.3%.

Micron up on mixed news

Micron is up 4.0%, the biggest gainer on the list. The headlines are a mix: DA Davidson raised its price target while the stock dipped premarket, Micron's Taiwan union voted to authorise a strike over bonus structure, ETFs were net sellers on 5 October, and Netlist surged 18% on a $600 million licensing deal with Micron. All headline only.

NetApp upgrade cluster

NetApp is up 3.3% on a clear analyst cluster. Evercore ISI upgraded the stock and raised its target to $300, citing a strong FY27 growth outlook per the headlines, and TD Cowen kept its rating with a target raised to $250. Investor's Business Daily also flagged the upgrade after a big rally. All headline only, but the direction of the notes is consistent.

SpaceX dominates volume, down on the debt story

SpaceX is down 2.5% and accounts for the largest single block of items here. The driver, reported first by the FT and repeated across a dozen outlets, is a plan to raise around $40 billion in financing led by Apollo Global Management to buy Nvidia chips. One wire post notes shares fell 1.5% on that report, and Investing.com's premarket movers piece names SpaceX debt plans as a weight on the tape. Alongside it: Susquehanna raised its target to $173 from $144, Goldman Sachs also lifted its target, Morgan Stanley weighed in, Cathie Wood trimmed the position, and Musk clarified SpaceX's role in the TSMC Terafab project without a deal in place, which a separate headline links to TSMC weakness. Musk also posted on Starlink in India, V2 direct-to-cell satellites claiming over 100 times the bandwidth of V1, and Grok routing to third-party models including Claude Opus 5.5. All of this is headline level.

Semis and the rest

TSMC is down 1.9% with Citi and Barclays both raising targets, Barclays to $665, and headlines on a $100 billion capex expansion and four new US fabs, none of which were read in full. SanDisk is up 1.9% with a target raised to $2050. Astera Labs is down 1.8%, Coherent down 1.0%, both with "why is the stock sliding" pieces that are headline only. BWXT is down 2.8% despite headlines about a new microreactor project and a 7.5% rise; Truist lowered its target to $182. TD Synnex, down 2.6%, agreed to acquire specialty distributor BlueStar. Aflac has five separate broker notes pointing in different directions and is down 1.0%.

Quiet names

Apple is up 0.9% with heavy but low-substance flow: smart home launch on 13 October with an LG partnership, App Store revenue growth UBS isn't ready to call a turnaround, an EU tech tax proposal, and a long run of ETF flow notes. Broadcom, Oracle, Netflix, Costco and the smaller names are all within a point either way and carry nothing beyond routine broker notes, ETF flow tallies and chart posts.